The Fashion Industry Faces Backlash Over Lack of Plus-Size Models
In a striking turn of events, the Fall-Winter 2023 fashion runways exhibited a marked decrease in the presence of plus-size models, sparking criticism among advocates for diversity and inclusivity in fashion. This trend arrives amid a significant rise in appetite-suppressant medications available in the U.S. and the U.K., which raises questions about the industry’s commitment to representing a spectrum of body types.
Why It Matters
The fashion industry’s reluctance to embrace size diversity not only undermines progress made in recent years but also poses potential risks exacerbated by the rising popularity of weight-loss medications. Such developments highlight a troubling disconnect between consumer needs and industry standards, often reinforcing narrow beauty ideals that fail to reflect the average woman’s body size.
Key Developments
- A reported 24% decline in mid and plus-size models on key runways compared to Spring-Summer 2023.
- Vogue Business data indicates that 95.6% of looks presented for Fall-Winter 2023 were in sizes US 0-4.
- Critics, including IMG model agent Mina White and fashion journalist Amy Odell, decry this regression as a blatant disregard for body diversity.
- While few major brands have stepped up, smaller labels like Di Petsa and Esther Manas continue to champion inclusivity.
Full Report
Industry Criticism
Many fashion commentators have voiced disappointment at this regression, which starkly contrasts with previous seasons that saw an increase in size diversity. Mina White noted that seeing prominent plus-size figures like Ashley Graham in attendance, yet absent from the runways, was particularly disheartening. Critics argue that despite the industry’s attempts to leverage diverse images, runway shows remain unreflective of broader societal body types.
Positive Developments Amidst Decline
Amidst the broader issue, certain brands have maintained a commitment to inclusivity. Labels such as Christian Siriano and Esther Manas showcased diverse models, emphasizing that a range of body types can be included in high fashion.
Medical Context
The backdrop of this discussion is further complicated by the availability of new appetite-suppressant medications, such as Wegovy and Ozempic, which have been interpreted as solutions for those struggling with weight management. These medications, originally developed for diabetes treatment, are being increasingly discussed in social circles as quick fixes for aesthetic goals, raising ethical concerns about misuse.
Context & Previous Events
Historically, fashion has often marginalized plus-size individuals, with notable occasions such as Jill Kortleve and Paloma Elsesser walking for Fendi in 2020 marking a shift towards inclusivity. However, recent seasons have seen a concerning rollback in this progress. Reports indicate that 68% of American women wear sizes US 14 or above, yet the industry continues to prioritize a limited size range in runway presentations.
